Abstract Background: Sphingomonas paucimobilis is a gram-negative pathogen that causes urinary tract infections, diarrhea, septicemia, and wound infections. Due to the spread of patients with high mortality but low mortality in Sphingomonas paucimobilis, it has been isolated from different clinical samples and is increasing antibiotic resistance all over the world. Objectives: The aim of our research was to look at the epidemiology, antibiotic susceptibility series, and pathogenic potential of clinical samples from Erbil's Rizgary and Raparin hospitals. Materials and Methods: A total of 2582 samples were reviewed from different clinical samples from Rizgary Hospital and Raparin Hospital from male and female, we found 24 Sphingomonas paucimobilis isolates, identified by using microscopical, morphological, biochemical tests and Vitek2 compact system according to the standard protocol against Ampicillin/Sulbactam, Cefazolin, Ceftazidime, Ceftriaxone, Cefepime, Imipenem, Tobramycin, Ciprofloxacin, Lev- ofloxacin, Trimethoprim. using Vitek 2 compact system. Results: 24 total positive results of Sphingomonas paucimobilis isolated from 2582 different clinical specimens the highest percentage of Sphingomonas paucimobilis was isolated from female samples (65%) while from male (35%) wen performing antibiotic susceptibility the highest resistance rate was Trimethoprim (66.66%), followed by To bramycin (50%), Ciprofloxacin (50%) and Levofloxacin (41.66%), respectively in contrast the highest effective antibiotic against Sphingomonas paucimobilis was Cefepime (75%), Imipenem (75%), followed by Ceftriaxone (66.66%), Ceftazidime (66.66%), Cefazolin (66.66%), Ampicillin/Sulbactam (66.66%) Conclusion: Morbidity attribute to antibiotic resistance to third generation cephalosporin resistant, Sphingomonas paucimobilis resistant is significant, if prevailing resistance trends continue, high societal and economic costs can be expected. Better management of antibiotic use, and infection control is needed to avoid infections that caused by drug resistant pathogens like Sphingomonas paucimobilis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.